Drugs / TA103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04883593 | Sep 2020 → Feb 2021 | tinea pedis | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TA103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04883593 ↗ |
| Route | Topical | “applied to the skin” NCT04883593 ↗ |